Researchers develop magnetic nanoparticles for bone cancer treatment

Scientists from Brazil and Portugal have created a magnetic nanocomposite that targets bone cancer cells while promoting bone regeneration. The material uses heat from a magnetic field to destroy tumors and a bioactive coating to aid healing. This innovation could enable less invasive therapies for bone tumors.

Researchers from Brazil and Portugal have engineered a magnetic core-shell nanocomposite to combat bone cancer and support tissue repair. Published in Magnetic Medicine in 2025, the material consists of iron oxide nanoparticles coated with bioactive glass. This structure allows it to generate heat under an alternating magnetic field, enabling magnetic hyperthermia to ablate tumor cells selectively without widespread damage to healthy tissue.

The bioactive glass layer enhances the material's integration with bone. In tests using simulated body fluid, the nanocomposites rapidly formed apatite, a mineral akin to that in natural bone, indicating strong potential for bonding and regeneration. Among various formulations, the one with elevated calcium content excelled, showing the quickest mineralization and most robust magnetic properties.

"Magnetic bioactive nanocomposites are very promising for bone cancer therapy because they can simultaneously ablate tumors through magnetic hyperthermia and support new bone growth," stated Dr. Ângela Andrade, the lead author. She highlighted the challenge overcome: achieving both high magnetization and bioactivity in a single material.

Further, Andrade noted, "Among the tested formulations, the one with a higher calcium content demonstrated the fastest mineralization rate and the strongest magnetic response, making it an ideal candidate for biomedical applications."

This dual-function approach addresses both tumor elimination and structural recovery in one procedure. "This study provides new insights into how surface chemistry and structure influence the performance of magnetic biomaterials," Andrade added, suggesting pathways for safer, more effective clinical tools in oncology and regenerative medicine.

The work, detailed by authors including Andreia Batista and José Domingos Fabris, appears in Magnetic Medicine (2025; 1(3):100039). It represents a step toward multifunctional nanomaterials for minimally invasive bone cancer treatments.

Articoli correlati

Illustration of scientists in a lab studying a miniature human bone marrow model, depicting blood cell production for medical research.
Immagine generata dall'IA

Researchers build functional miniature human bone marrow model

Riportato dall'IA Immagine generata dall'IA Verificato

Scientists at the University of Basel report a three-dimensional human bone marrow model built entirely from human cells. The lab-grown system replicates the endosteal niche and sustains blood cell production for weeks, a step that could accelerate blood cancer research and reduce some animal testing.

Scientists at RMIT University have created tiny molybdenum oxide nanodots that destroy cancer cells by amplifying their internal stress, while leaving healthy cells largely intact. In lab tests, these particles proved three times more effective against cervical cancer cells than healthy ones. The early-stage research points to a potential for more precise cancer treatments.

Riportato dall'IA

Scientists have created innovative nanoparticles designed to destroy harmful proteins linked to dementia and cancer. These particles can access difficult tissues like the brain and precisely eliminate problematic proteins without broad side effects. The technology shows early promise for precision medicine.

Researchers have developed tiny ingestible hydrogel microspheres packed with engineered bacteria that glow when they encounter blood in the gut, potentially offering a quick, noninvasive way to monitor intestinal disease. In mouse models of colitis, the sensors detected heme — a component of blood — within minutes and produced stronger signals as disease severity increased.

Riportato dall'IA Verificato

A small study from researchers in India has found that a short course of an oral combination of resveratrol and copper was associated with reduced biological markers of aggressiveness in glioblastoma tumors, without reported side effects. Patients who took the nutraceutical before surgery showed lower levels of several key cancer-related markers in their tumor samples, and the approach targets harmful DNA-containing particles released from dying cancer cells.

Researchers from MIT and Stanford University have developed multifunctional molecules called AbLecs to block sugar-based immune checkpoints on cancer cells. This approach aims to enhance immunotherapy by allowing immune cells to better target tumors. Early tests in cells and mice show promising results in boosting anti-tumor responses.

Riportato dall'IA Verificato

A Cell Press review published on November 5, 2025, highlights tiny camelid-derived antibodies known as nanobodies as potential tools for treating conditions such as Alzheimer’s disease and schizophrenia. The authors say these proteins can reach brain targets in mice more readily than conventional antibodies and outline key steps before human testing.

 

 

 

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta